MedTrace Logo

MRE Predictors of Disease Relapse After Stopping Biologics

NCT06124287 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-05-13

No results posted yet for this study

Summary

This study aims to investigate if MR Enterography (MRE) improves the ability to predict which Crohn's disease patients will relapse quickly (disease comes back) after stopping biologic medication. MRE is a safe MRI scan of the bowel, widely used in Crohn's disease patients.

Conditions

Interventions

DIAGNOSTIC_TEST

MR Enterography (MRE)

MRI scan

Sponsors & Collaborators

  • British Society of Gastrointestinal and Abdominal Radiology (BSGAR)

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • Maira Hameed · University College London Centre for Medical Imaging

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-27
Primary Completion
2026-08-31
Completion
2027-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124287 on ClinicalTrials.gov